Alejandro Szmulewicz

Dr. Alejandro Szmulewicz


Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
20 November 2018 in Clinical Obesity
Verified
Journal Article
Closed access
PDF file
ASAlejandro Szmulewicz
Alejandro Szmulewicz
KWKerollos N. Wanis
Kerollos N. Wanis
AGAshley Gripper
Ashley Gripper
FAFederico Angriman
Federico Angriman
JHJeff Hawel
Jeff Hawel
CSChristopher M. Schlachta
Christopher M. Schlachta

21 September 2019 in Bipolar Disorders
Verified
Journal Article
Closed access
PDF file
ASAlejandro Szmulewicz
Alejandro Szmulewicz
MVMarina P. Valerio
Marina P. Valerio
DMDiego Martino
Diego Martino

1 February 2017 in Psychiatry Research
Verified
Journal Article
Closed access
ASAlejandro Szmulewicz
Alejandro Szmulewicz
MVMarina P. Valerio
Marina P. Valerio
JSJosé M. Smith
José M. Smith
CSCecilia Samamé
Cecilia Samamé
DMDiego J. Martino
Diego J. Martino
SSSergio A. Strejilevich
Sergio A. Strejilevich

1 July 2018 in Psychiatry Research
Verified
Journal Article
Closed access
MVMarina P. Valerio
Marina P. Valerio
ASAlejandro Szmulewicz
Alejandro Szmulewicz
DMDiego Martino
Diego Martino

24 February 2015 in International Journal of Bipolar Disorders
Verified
Journal Article
Open access
PDF file
ASAlejandro Szmulewicz
Alejandro Szmulewicz
MVMarina P Valerio
Marina P Valerio
JSJose M Smith
Jose M Smith
There is an increasing use of ayahuasca for recreational purposes. Furthermore, there is a growing evidence for the antidepressant properties of its components. However, there are no reports on the effects of this substance in the psychiatric setting. Harmaline, one of the main components of ayahuasca, is a selective and reversible MAO-A inhibitor and a serotonin reuptake inhibitor. We present the case of a man with bipolar disorder who had a manic episode after an ayahuasca consumption ritual. This patient had had at least one hypomanic episode in the past and is currently depressed. We discuss the diagnostic repercussion of this manic episode. There is lack of specificity in the diagnosis of substance-induced mental disorder. The knowledge of the pharmacodynamic properties of ayahuasca consumption allows a more physiopathological approach to the diagnosis of the patient.

3 March 2017 in Acta Psychiatrica Scandinavica
Verified
Journal Article
Closed access
PDF file
ASAlejandro Szmulewicz
Alejandro Szmulewicz
FAF. Angriman
F. Angriman
CSC. Samamé
C. Samamé
AFA. Ferraris
A. Ferraris
DVD. Vigo
D. Vigo
SSS. A. Strejilevich
S. A. Strejilevich